Latest filing published 22 May 2026 for ALNYLAM PHARMACEUTICALS, INC..
No signal scores available.
Margaret A. Hamburg has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Henry Schein Inc and Alnylam Pharmaceuticals, Inc. Between 2 March 2006 and 20 May 2026, the trades on record add up to 13 filings.
Sales make up the whole of the open-market record (2 sales, €1.7M). Other entries cover 6 share grants and 4 option exercises.
The latest filing, published on 22 May 2026, reports a share grant in Alnylam Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations